https://www.sec.gov/Archives/edgar/data/1596946/000179686122000007/formsc13d.htm
‘New Phase 3 Data Presented At WORLDSymposium Reinforce Nexviazyme As Potential New Standard Of Care For All People Living With Late-Onset Pompe Disease’
New Phase 3 data presented at WORLDSymposium™ reinforce Nexviazyme® (avalglucosidase alfa) as potential new standard of care for all people living with
